Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Emu Net Zero Pathway Paris Aligned UCITS ETF 1c

IE000Y6L6LE6 · IE000Y6L6LE6 · EUR · domicile Ireland
Equity · Eurozone · Sustainable / ESGSFDR art. 8
Index tracked: Solactive ISS ESG Developed Markets Eurozone Net Zero Pathway Index (EUR)
TER
0.15%+ trans. 0.06%
Fund size
9 m EUR
Tracking difference
+0.31%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 17 Feb 2022 · costs from the KID as of 2 Sept 2026 · 131 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The fund aims to reflect the performance of the Solactive ISS ESG Developed Markets Eurozone Net Zero Pathway Index (index). DESCRIPTION OF INDEX: The Reference Index is designed to reflect the performance of large and medium capitalisation companies across developed market countries in the European Economic and Monetary Union which are selected and weighted with the aim of seeking alignment with EU Paris-aligned Benchmark (EU PAB) standards and certain net zero frameworks. The index uses ESG data…

Performance since series start (in euro) — base 100

17 Feb 20228 Sept 2026 · dividends reinvested where declared by the issuer
202320242025202614980146
High 149 (13 Aug 2026) · low 80 (12 Oct 2022) · last 146. Past performance is not indicative of future results.

Returns in euro

1 year+19.1%
3 years+43.7%
5 yearsseries too young
10 yearsseries too young
Since series start+45.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.18%14.52%
Max drawdown−11.55%−17.03%
Sharpe1.030.67
Sortino1.590.97
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE000Y6L6LE6 · IE000Y6L6LE61
RebalixIE000Y6L6LE6 · IE000Y6L6LE6 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+12.94%+12.71%+0.24%
2024+6.95%+6.66%+0.29%
2023+19.72%+19.32%+0.40%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 131 securities · top-10 weight = 35.7%
Top holdingsWeight
ASML HOLDING11.0%
SIEMENS N AG3.7%
BANCO SANTANDER3.3%
SAP3.3%
ALLIANZ3.1%
SCHNEIDER ELECTRIC3.0%
BANCO BILBAO VIZCAYA ARGENTARIA SA2.3%
LVMH2.1%
LAIR LIQUIDE SOCIETE ANONYME POUR2.0%
UNICREDIT1.9%
Countries (% of fund)
Germany24.9%France21.5%Netherlands19.0%Spain9.3%Italy8.4%
Sectors (% of fund)
Financials25.4%Technology20.3%Industrials14.3%Consumer Discretionary10.7%Health Care9.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
XNZE · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/009037a7-78ae-4d3f-81d1-ef114e6051bf
Factsheet · etf.dws.com/download/asset/f6e62af3-e68c-452f-b8c3-9211a233135b
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE000Y6L6LE6
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE000Y6L6LE6 · IE000Y6L6LE62